Array
(
[id] => 7082637
[patent_doc_number] => 20050048017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Use of surfactants with a ratio of hemolysis value to denaturation index of greater than or equal to 1 for obtaining or increasing the selectivity of cleansing preparations'
[patent_app_type] => utility
[patent_app_number] => 10/490890
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3336
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048017.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490890
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490890 | Use of surfactants with a ratio of hemolysis value to denaturation index of greater than or equal to 1 for obtaining or increasing the selectivity of cleansing preparations | Aug 22, 2002 | Abandoned |
Array
(
[id] => 6658385
[patent_doc_number] => 20030133975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same'
[patent_app_type] => new
[patent_app_number] => 10/200029
[patent_app_country] => US
[patent_app_date] => 2002-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5916
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0133/20030133975.pdf
[firstpage_image] =>[orig_patent_app_number] => 10200029
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/200029 | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same | Jul 18, 2002 | Issued |
Array
(
[id] => 7466364
[patent_doc_number] => 20040198710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Drug delivery system comprising a tetrahydroxilated estrogen for use in hormonal contraception'
[patent_app_type] => new
[patent_app_number] => 10/478365
[patent_app_country] => US
[patent_app_date] => 2004-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10140
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198710.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478365
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478365 | Drug delivery system comprising a tetrahydroxilated estrogen for use in hormonal contraception | May 22, 2002 | Issued |